Baker Brothers Life Sciences LP, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), bought 124,482 shares at $168.78 ($22.1M) on 2023-11-17, disclosed to the SEC on 2023-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.63 | 646 | $108K | 0.5% |
| 2 | $167.63 | 54 | $9K | 0.0% |
| 3 | $167.63 | 646 | $108K | 0.5% |
| 4 | $168.78 | 1,107 | $187K | 0.8% |
| 5 | $168.78 | 1,107 | $187K | 0.8% |
| 6 | $168.78 | 93 |
| $16K |
| 0.1% |
| 7 | $171.79 | 461 | $79K | 0.4% |
| 8 | $171.79 | 461 | $79K | 0.4% |
| 9 | $171.79 | 39 | $7K | 0.0% |
| 10 | $173.20 | 4,151 | $719K | 3.2% |
| 11 | $173.20 | 4,151 | $719K | 3.2% |
| 12 | $173.20 | 350 | $61K | 0.3% |
| 13 | $173.20 | 350 | $61K | 0.3% |
| 14 | $173.75 | 1,660 | $288K | 1.3% |
| 15 | $173.75 | 140 | $24K | 0.1% |
| 16 | $174.67 | 978 | $171K | 0.8% |
| 17 | $174.67 | 82 | $14K | 0.1% |
| 18 | $174.67 | 978 | $171K | 0.8% |
| 19 | $174.87 | 18,125 | $3.2M | 14.3% |
| 20 | $174.87 | 1,528 | $267K | 1.2% |
| 21 | $174.87 | 1,528 | $267K | 1.2% |
| 22 | $174.87 | 18,125 | $3.2M | 14.3% |
| 23 | $175.72 | 4,923 | $865K | 3.9% |
| 24 | $175.72 | 415 | $73K | 0.3% |
| 25 | $175.72 | 415 | $73K | 0.3% |
| 26 | $175.72 | 4,923 | $865K | 3.9% |
| 27 | $175.82 | 903 | $159K | 0.7% |
| 28 | $175.82 | 10,715 | $1.9M | 8.5% |
| 29 | $175.82 | 903 | $159K | 0.7% |
| 30 | $175.82 | 10,715 | $1.9M | 8.5% |
| 31 | $181.93 | 153 | $28K | 0.1% |
| 32 | $181.93 | 1,847 | $336K | 1.5% |
| 33 | $181.93 | 1,847 | $336K | 1.5% |
| 34 | $183.40 | 7,010 | $1.3M | 5.8% |
| 35 | $183.40 | 579 | $106K | 0.5% |
| 36 | $183.40 | 579 | $106K | 0.5% |
| 37 | $185.87 | 1,206 | $224K | 1.0% |
| 38 | $185.87 | 100 | $19K | 0.1% |
| 39 | $185.87 | 1,206 | $224K | 1.0% |
| 40 | $187.35 | 4,895 | $917K | 4.1% |
| 41 | $187.35 | 4,895 | $917K | 4.1% |
| 42 | $187.35 | 405 | $76K | 0.3% |
| 43 | $187.35 | 405 | $76K | 0.3% |
| 44 | $188.84 | 95 | $18K | 0.1% |
| 45 | $188.84 | 1,147 | $217K | 1.0% |
| 46 | $188.84 | 1,147 | $217K | 1.0% |
| 47 | $189.70 | 3,022 | $573K | 2.6% |
| 48 | $189.70 | 3,022 | $573K | 2.6% |
| 49 | $189.70 | 250 | $47K | 0.2% |
| Total | $177.85 avg | 124,482 | $22.1M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |
| NLTX | BUY | 2023-08-17 | $2.9M | — | Filing → |